Mereo BioPharma
Setrusumab partnered with UltragenyxMereo BioPharma
Targeting TIGIT thoughtfullyMereo BioPharma
H120 results and corporate reviewMereo BioPharma
TIGIT programme starts the next chapterMereo BioPharma
Private placement raises $70m (£56m)Mereo BioPharma
Funding deals worth up to $33m announcedMereo BioPharma
Additional ASTEROID data supports progressionMereo BioPharma
Oncologie takes global licence to NaviMereo BioPharma
Underappreciated and undervaluedMereo BioPharma
Setrusumab ready to advance into pivotal studies